Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) just unveiled an update.
Proteomics International Laboratories has completed a strategic review and begun transforming from a predominantly research-driven organisation into a commercially focused diagnostics business. The company plans to leverage its proteomics expertise and accredited labs to build a disciplined portfolio of validated tests, prioritising distributor partnerships in Australia and the U.S., structured reimbursement strategies, and capital-efficient commercial execution.
As part of the shift, Proteomics International has discontinued its direct-to-consumer model, restructured operations with about 25% of positions made redundant, and implemented leadership changes including the appointment of David Morris as CEO and managing director. The company continues to advance its Promarker Endo and Promarker Eso assays, review its IP and OxiDX unit, and ended the March quarter with $5.7 million in cash after $2.6 million in operational outflows and $0.7 million from option exercises.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is an Australian precision diagnostics company that integrates proteomics expertise with accredited laboratory operations to develop clinically validated prognostic and diagnostic tests. The company focuses on commercialising its portfolio through distributor-led models in markets such as Australia and the U.S., with an emphasis on regulatory compliance, reimbursement pathways, and capital-efficient growth.
Average Trading Volume: 402,573
Technical Sentiment Signal: Sell
Current Market Cap: A$46.25M
For detailed information about PIQ stock, go to TipRanks’ Stock Analysis page.